Welcome to the Ypsomed Blog

Stay informed with expert insights on digital selfcare, connected drug delivery, and the future of self-medication. The Ypsomed blog is your go-to source for trends, innovations, and thought leadership in the evolving healthcare landscape.

Moving faster, with confidence: An interview with Ulrike Bauer, Chief Business Officer at Ypsomed

How can pharma and biotech companies accelerate drug-device programs without shifting risk or bottlenecks further downstream? In this interview, Ypsomed Chief Business Officer Ulrike Bauer discusses how platform flexibility, device readiness and …
Read more...

For the record: How past experience enables future success

Jakob Lange and Shawn James discuss the value of the experience hidden behind metrics such as completed projects and commercialized devices – the wealth of accumulated process knowledge that enables a company to bring hard-learned lessons forwards.
Read more...

The story behind MIDBA: An exclusive interview

Ypsomed experts Thomas Fontanellaz, Category Lead YposoMate 1mL and 2.25 mL, and Karolina Snajdarova, Regulatory Affairs Manager, discuss the science, regulatory significance, and business impact of the EMA-qualified MIDBA approach.
Read more...

MIDBA: A new regulatory approach to clinical device bridging 

The development of drug-device combination products continues to evolve, with increasing attention on how clinical bridging between different delivery systems is handled. In this context, regulatory approaches that support more efficient and …
Read more...

Biobased plastics in drug delivery: From material equivalence to systemic decarbonization

Biobased plastics can cut carbon without changing performance or regulatory status. In our latest blog, Nadine Kaufmann and Michael Schori explore how material equivalence, lifecycle thinking, and scale enable real decarbonization in drug delivery …
Read more...

Interview: Enhancing Clinical Trials with CliniPilot and Clear to Clinic Programme

In this exclusive interview, Dr Carolina Canapè and Roger Lüscher talk with ONdrugDelivery’s Guy Furness about the application of connectivity in decentralised trials, and how Ypsomed’s CliniPilot and the company’s range of clinic-ready autoinjectors …
Read more...

The compass for innovation: Regulatory Affairs at Ypsomed

Acting as the compass for innovation, Ypsomed’s regulatory strategy steers ideas through development to deliver safe, compliant solutions to patients worldwide.
Read more...

Self-injection device manufacturing in a dynamic world

How did pen-inspired injectors evolve into today’s flexible self-injection platforms? Discover the trends in usability, scale-up, and resilient manufacturing that are shaping the future of drug delivery in a fast-changing industry landscape.
Read more...

Optimizing high-dose delivery

Subcutaneous injection or high-dose formulations requires optimized solutions. This joint article by Ypsomed and BD explores how YpsoMate 2.25 and BD Neopak™ syringes perform across a range of viscosities.
Read more...
Load more